Eric Weisblum bought $1,376 of SILO
CEO and President at Silo Pharma, Inc.. 1,000 shares at an average of $1.38, traded Dec 5, 2023, filed Dec 7, 2023.
Score components
- +25RoleCEO
- 0Trade size$1k at market
- -5Relative to holdingsUnder 1% of holdings (0.6%)
- +18Price context7% above the 52-week low; 62% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying5 buys in 90 days
- -5Track recordMedian 6-month excess return -16% over 6 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.4%, 3m +4.1%, 6m -20.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-23-094145, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 5, 2023 | POpen-market purchase Common Stock | +600 | $1.39 | $834 | 167,724 | Dec 7, 2023 |
| Dec 6, 2023 | POpen-market purchase Common Stock | +76 | $1.34 | $102 | 167,800 | Dec 7, 2023 |
| Dec 7, 2023 | POpen-market purchase Common Stock | +324 | $1.36 | $441 | 168,124 | Dec 7, 2023 |
Related signals
Other insiders at Silo Pharma, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum Chief Executive Officer | $2,075 5,000 shares | +2% | |
| 43Moderate | SILObuy Silo Pharma, Inc. | Eric Weisblum Chief Executive Officer | $735 2,000 shares | +1% | |
| 46Moderate | SILObuy Silo Pharma, Inc. | Eric Weisblum Chief Executive Officer | $4,847 12,000 shares | +6% | |
| 46Moderate | SILObuy Silo Pharma, Inc. | Eric Weisblum Chief Executive Officer | $4,329 10,000 shares | +5% | |
| 30Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $2,097 2,500 shares | +1% | |
| 25Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $4,625 5,000 shares | +3% | |
| 43Moderate | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $5,533 5,000 shares | +3% | |
| 24Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $1,988 1,000 shares | +1% | |
| 24Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $8,713 4,508 shares | +3% | |
| 28Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $1,137 700 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.